tyrphostin a9 has been researched along with Glioblastoma in 2 studies
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yadav, N | 1 |
| Babu, D | 1 |
| Madigubba, S | 1 |
| Panigrahi, M | 1 |
| Phanithi, PB | 1 |
| Liang, BC | 1 |
| Ullyatt, E | 1 |
2 other studies available for tyrphostin a9 and Glioblastoma
| Article | Year |
|---|---|
Tyrphostin A9 attenuates glioblastoma growth by suppressing PYK2/EGFR-ERK signaling pathway.
Topics: Animals; Astrocytoma; ErbB Receptors; Focal Adhesion Kinase 2; Glioblastoma; Glioma; Phosphorylation | 2023 |
Chemosensitization of glioblastoma cells to bis-dichloroethyl-nitrosourea with tyrphostin AG17.
Topics: Apoptosis; Brain Neoplasms; Carmustine; Cell Division; Cell Survival; Chromatin; Enzyme Inhibitors; | 1998 |